Zurueck zur Suche

Reporte zur Charge U039906

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 WA 1 TX 1 CA 1 AZ 1 NE 1 NC 1 HI 1 IA 1

VAERS 2398188

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

schwer
Staat
MI
Alter
22,0
Geschlecht
M
Eingang
01.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Syncope

Symptomtext

Went over all patient information and vaccine information prior to administration. Patient was given VIS Fact Sheet for MMR-II vaccine. After vaccine administration patient fainted and fell to the ground. Patient did not lose consciousness and was verbal throughout encounter. He wanted to stand immediately after fall but was told to take a few minutes. He was then directed to chair and further monitored. He refused ambulance services and said he was feeling fine and stated that he had not eaten all day, he had only drank coffee. Patient left pharmacy in good and was feeling well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2648894

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

mild
Staat
WA
Alter
1,5
Geschlecht
F
Eingang
23.06.2023
Impfdatum
21.06.2023
Beginn
21.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Injection site erythema Injection site swelling Irritability Product preparation error Pyrexia Rash

Symptomtext

Medical assistant administered new, undiluted 10-dose vial of Pfizer Bivalent 6m-4y vaccine as a single dose to patient in error. Parent was contacted the following day (6/22/23) when error was discovered. Parent reported patient to have experienced fever of 102F on the evening following vaccination, rash from belly to left thigh, and redness and swelling at both injection sites. Follow up by phone on 6/23/23, parent reported fever waxed and waned over 6/22/23, but at present no longer experiencing fever, belly/thigh rash no longer present, continued clinically expected redness at both injection sites. Parent noted increased fussiness as well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Fever reported 6/5/23.
Vorgeschichte
None known
Andere Medikamente
None reported
Allergien
None known
Vorherige Impfungen
-

VAERS 2625890

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u039906

mild
Staat
TX
Alter
19,0
Geschlecht
M
Eingang
03.05.2023
Impfdatum
03.05.2023
Beginn
01.05.2023
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Flushing Pruritus Throat irritation Urticaria

Symptomtext

Hives, facial flushing and itchiness, scratchy throat. Treatment: Famotidine 20mg PO, Benadryl 25mg PO, Prednisone 20mg PO, Epinephrine 20mg/ml- 0.3 ml IM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
cold
Vorgeschichte
none
Andere Medikamente
none
Allergien
avocado banana legumes peanut pea tree nut watermelon egg
Vorherige Impfungen
Flu

VAERS 2622299

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

mild
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
27.04.2023
Impfdatum
26.04.2023
Beginn
27.04.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Per mother, patient has right upper arm swollen, red and hot to the touch on injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2529029

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

mild
Staat
AZ
Alter
1,1
Geschlecht
M
Eingang
12.12.2022
Impfdatum
12.12.2022
Beginn
12.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

Gave vaccine and after vaccines were given patients started having hives on his face

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
unknown
Vorgeschichte
no
Andere Medikamente
no medications
Allergien
unknown
Vorherige Impfungen
-

VAERS 2492523

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

mild
Staat
NE
Alter
22,0
Geschlecht
F
Eingang
28.10.2022
Impfdatum
26.10.2022
Beginn
27.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Erythema Headache Rash Rash pruritic Skin burning sensation Vomiting

Symptomtext

Patient reported her "skin is on fire", she said it "feels like a really bad sunburn". She reported a headache, vomiting, chills, redness on the back of her neck and bilateral legs as well as small red/ itchy bumps on her back and neck.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
COVID positive on 09/15/2022
Vorgeschichte
gastroparesis, bipolar disorder, anxiety, PTSD
Andere Medikamente
Sertaline, Seroquel, hydroxyzine, Clonidine, Omeprazole
Allergien
Codeine
Vorherige Impfungen
-

VAERS 2468323

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

mild
Staat
NC
Alter
24,0
Geschlecht
M
Eingang
04.10.2022
Impfdatum
19.08.2022
Beginn
24.08.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bacterial test positive Blood immunoglobulin G normal Blood immunoglobulin M Chills Culture positive Culture urine negative Ear pain Erythema Full blood count Hyperhidrosis Mononucleosis heterophile test negative Mumps antibody test negative Mumps antibody test positive Pain in jaw Rubulavirus test Sialoadenitis Smear buccal normal Streptococcus test negative

Symptomtext

Received MMR vaccine 8/19/22. Symptoms of chills/sweats, L jaw swelling/pain, L ear pain, erythema to skin over mastoid process began 8/24/22. Diagnosed with acute sialoadenitis. Treatment included amoxicillin/clavulanate 875/125 PO BID x 10 days, ceftriaxone 1 g IM x 1, naproxen 500 mg PO BID x 7 days. Noted improvement by 8/29 with complete resolution by 9/6/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
8/26/22: negative rapid strep, negative mononucleosis. CBC with WBC 5.08, Mumps IgM 5.52 (positive), MumpsIgG < 9 (negative/non-immune), upper respiratory culture showed mixed growth w/ gram negative rods and routine respiratory flora, heavy growth. Mumps viral culture urine negative. 8/29/22: Mumps viral culture buccal swab negative. 9/20/22: Mumps IgG positive at 150, immune
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2654941

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

gering
Staat
MI
Alter
31,0
Geschlecht
F
Eingang
11.07.2023
Impfdatum
11.07.2023
Beginn
11.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error Wrong product administered

Symptomtext

Client had appointment for 2nd Adult Hep B dose. Also due for MMR. Vaccination admin error and Hep A admin'd in error. Client waited 15 minutes in lobby after administration and then left. Nurse contacted client to have them return for proper, 2nd Hep B dose

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2616419

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

gering
Staat
HI
Alter
-
Geschlecht
U
Eingang
18.04.2023
Impfdatum
22.03.2023
Beginn
22.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No AE/PQC; MMR-II was inadvertently administered after a supported temp excursion; This spontaneous report was received from the Medical Assistant, and refers to a patient of unknown age, and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not provided. On 22-MAR-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (recombinant Human albumin) subcutaneous injection, lot #U039906, verified to be valid (after internal review), expiration date: 16-DEC-2023, administered for prophylaxis (strength, and route of administration were not provided). The vaccine was inadvertently administered after a supported temp excursion: 9.1 C for 4 hours and 54 minutes. There was no previous temperature excursion (discrepancy, as HCP called back to report multiple excursions on different dates). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2439314

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U039906

gering
Staat
IA
Alter
1,0
Geschlecht
F
Eingang
10.09.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

No additional AE reported; a patient received a dose of PROQUAD and a dose of MMRII; This spontaneous report has been received from a registered nurse regarding a 1-year-old female patient. The patient's concurrent conditions, pertinent medical history, and drug reactions/ allergies were not reported. Concomitant medication included sterile diluent (MERCK STERILE DILUENT) (lot number: W000452, expiration date 23-JUL-2024). On 12-AUG-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (albumin status recombinant Human albumin (rHA)) lot #W010527, expiration date: 25-SEP-2023 (strength, dose, route of administration, and anatomical location were not provided), and a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA, lot #U039906, expiration date: 16-DEC-2023 (strength, dose, route of administration, and anatomical location were not provided) for prophylaxis (overdose). There was no additional adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-